Artery Stenosis Drug Market Indication Type, Size, Share, Trends and Growth

Data Bridge Market Research analyses that the artery stenosis drug will exhibit a CAGR of around 5.90% for the forecast period of 2022 to 2029. Growing demand for targeted mode of therapies, surge in the research and development activities for the development of novel drugs and therapies, increasing patient awareness regarding early detection, prevention, and treatment of strokes and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of artery stenosis drug market.

Artery stenosis is a medical condition wherein the arteries that are responsible for supplying oxygen rich blood to the vital organs shrink. This is because of the deposition of plaque on the walls of the arteries. Some common symptoms of this disease include mini-stroke, fainting and blurred vision.

Growing special designation from regulatory authorities coupled with upsurge in the prevalence of unhealthy lifestyle is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, growing geriatric population base, increase in the initiatives by the government to promote awareness in the backward areas, and upsurge in the strategic collaboration rate among the market players are other factors also fostering the growth of the market. Surging prevalence of diabetes and obesity is other determinant that will create lucrative market growth opportunities.

Access Full Report:
https://www.databridgemarketresearch.com/reports/global-artery-stenosis-drug-market

Global Artery Stenosis Drug Market Scope and Market Size
The artery stenosis drug market is segmented on the basis of indication type, treatment, drugs, route of administration, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on indication types, the artery stenosis drug market is segmented as carotid artery stenosis, renal artery stenosis, peripheral artery stenosis, coronary artery stenosis and others.
Based on treatment, the artery stenosis drug market is segmented as medication and surgery.
Based on the drugs, the artery stenosis drug market is segmented into atorvastatin, fluvastatin, heparin, minoxidil, aspirin and others.
Based on the route of administration, the artery stenosis drug market is segmented into oral and intravenous.
Based on the distribution channel, the artery stenosis drug market is segmented as hospital pharmacy, online pharmacy, retail pharmacy.
Based on end user, the artery stenosis drug market is segmented into hospitals, homecare, specialty clinics and others.

The major players operating in the artery stenosis drug market report are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company, CELGENE CORPORATION, Takeda Pharmaceutical Company Limited, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Baxter, Medtronic, Johnson & Johnson Services, Inc, Cook, Mallinckrodt and Lupin among others.

More Links:

https://dbmrbuisness.blogspot.com/2023/06/gastric-volvulus-treatment-market-it.html

https://www.databridgemarketresearch.com/reports/global-pharmaceutical-laboratory-information-management-systems-market

https://www.databridgemarketresearch.com/reports/global-lab-automation-market

https://www.databridgemarketresearch.com/reports/global-angioplasty-balloons-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.